KUROS BIOSCIENCES AG

KURN
Delayed Swiss Exchange - 11:30 2022-12-06 am EST
1.620 CHF -3.86%

Turn to zoom
Prev.1.62000000
Open1.68000000
High1.68000000
Low1.59000000
Volume3 186
Latest news
11/23
11/23
11/02
11/02
Chart KUROS BIOSCIENCES AG
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralBearish
Resistance1,782,001,75
Spread/Res.-9,0%-19%-7,4%
Spread/Supp.0,62%12%12%
Support1,611,451,45
Financials
Sales 2021 13,8 M 14,7 M 14,7 M
Net income 2021 -7,54 M -8,03 M -8,03 M
Net cash 2021 26,4 M 28,1 M 28,1 M
P/E ratio 2021 -8,37x
Yield 2021 -
Capitalization 59,2 M 63,0 M 63,0 M
EV / Sales 2020 9,97x
EV / Sales 2021 2,66x
Nbr of Employees 58
Free-Float 64,6%
Company
Kuros Biosciences AG is a Switzerland-based biotechnology company engaged in the discovery, development and commercialization of biopharmaceutical products known as Immunodrugs. Immunodrugs are therapeutic vaccines intended for treating and preventing common chronic diseases, such as hypertension,...
Sector :
Bio Therapeutic Drugs
Calendar :
2023-03-16 Earnings Release

Income Statement Evolution